Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Marja Hietarinta & Olli Lassila. (1996) Clinical Significance of Antinuclear Antibodies in Systemic Rheumatic Diseases. Annals of Medicine 28:4, pages 283-291.
Read now
Read now
Articles from other publishers (29)
Konstantinos Parperis, Avgoustina Kyriakou, Konstantinos Voskarides & Andreas Chatzittofis. (2022) Suicidal behavior in patients with systematic lupus erythematosus: Systematic literature review and genetic linkage disequilibrium analysis. Seminars in Arthritis and Rheumatism 54, pages 151997.
Crossref
Crossref
Desmond Y H Yap, Lorraine P Y Kwan, Maggie K M Ma, Maggie M Y Mok, Gary C W Chan & Tak Mao Chan. (2019) Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study. Nephrology Dialysis Transplantation 34:3, pages 467-473.
Crossref
Crossref
Tomonori Shigemura, Shunji Kishida, Satoshi Iida, Kazuhiro Oinuma, Junichi Nakamura, Kazuhisa Takahashi & Yoshitada Harada. (2012) Cementless total hip arthroplasty for osteonecrosis of the femoral head in systemic lupus erythematosus: a study with 10–16 years of follow-up. European Orthopaedics and Traumatology 4:1, pages 15-20.
Crossref
Crossref
Sean O’Neill & Ricard Cervera. (2010) Systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 24:6, pages 841-855.
Crossref
Crossref
MA RabbaniHB Habib, M. Islam, B. Ahmad, SMA Shah, S. Tahir, D. Merchant & A. Ahmad. (2010) Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan. Lupus 19:13, pages 1573-1578.
Crossref
Crossref
Kwi Young Kang, Hyun Ok Kim, Ho Sung Yoon, Jeniffer Lee, Won Chul Lee, Hyek-Jae Ko, Ji Hyeon Ju, Chul-Soo Cho, Ho-Youn Kim & Sung-Hwan Park. (2009) Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clinical Rheumatology 29:4, pages 381-388.
Crossref
Crossref
TRACY Y. ZHU, LAI-SHAN TAM, VIVIAN W.Y. LEE, KENNETH K. LEE & EDMUND K. LI. (2010) Relationship Between Flare and Health-related Quality of Life in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology 37:3, pages 568-573.
Crossref
Crossref
Reiko Tomioka, Kenji Tani, Keiko Sato, Chiyuki Suzuka, Yuko Toyoda, Jun Kishi & Saburo Sone. (2008) Observations on the occurrence of exacerbations in clinical course of systemic lupus erythematosus. The Journal of Medical Investigation 55:1,2, pages 112-119.
Crossref
Crossref
Murray B Urowitz. (2007) Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with SLE. Future Rheumatology 2:2, pages 139-141.
Crossref
Crossref
Matthew H. Liang & Julia F. Simard. (2006) The Large Print Giveth and the Small Print Taketh Away: Preemptive treatment of serologically active, clinically quiet systemic lupus erythematosus. Arthritis & Rheumatism 54:11, pages 3378-3380.
Crossref
Crossref
Chung-E Tseng, Jill P. Buyon, Mimi Kim, H. Michael Belmont, Meggan Mackay, Betty Diamond, Galina Marder, Pamela Rosenthal, Kathleen Haines, Virginia Ilie & Steven B. Abramson. (2006) The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism 54:11, pages 3623-3632.
Crossref
Crossref
Andrea Doria, Luca Iaccarino, Anna Ghirardello, Sandra Zampieri, Silvia Arienti, Piercarlo Sarzi-Puttini, Fabiola Atzeni, Antonio Piccoli & Silvano Todesco. (2006) Long-Term Prognosis and Causes of Death in Systemic Lupus Erythematosus. The American Journal of Medicine 119:8, pages 700-706.
Crossref
Crossref
A M Bertoli, M Fernández, J Calvo-Alén, L M Vilá, M L Sanchez, J D Reveille & G S Alarcón. (2016) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXXI: factors associated with patients being lost to follow-up. Lupus 15:1, pages 19-25.
Crossref
Crossref
Sònia Jiménez, Ricard Cervera, Miguel Ingelmo & Josep Font. 2005. Cutaneous Lupus Erythematosus. Cutaneous Lupus Erythematosus
33
44
.
Dafna D. Gladman. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
697
715
.
Ricard Cervera, Sònia Jiménez, Josep Font & Miguel Ingelmo. (2003) The epidemiology of systemic lupus erythematosus: a review of the current data with special emphasis on the lessons from the ‘Euro-lupus Cohort’. APLAR Journal of Rheumatology 6:2, pages 150-157.
Crossref
Crossref
Ricard Cervera, Munther A. Khamashta, Josep Font, Gian Domenico Sebastiani, Antonio Gil, Paz Lavilla, Juan Carlos Mejía, A. Olcay Aydintug, Hanna Chwalinska-Sadowska, Enrique de Ramón, Antonio Fernández-Nebro, Mauro Galeazzi, Merete Valen, Alessandro Mathieu, Frédéric Houssiau, Natividad Caro, Paula Alba, Manuel Ramos-Casals, Miguel Ingelmo & Graham R.V. Hughes. (2003) Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period. Medicine 82:5, pages 299-308.
Crossref
Crossref
Arthur F. Kavanaugh & Daniel H. Solomon. (2002) Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-DNA antibody tests. Arthritis & Rheumatism 47:5, pages 546-555.
Crossref
Crossref
Olivier Meyer. (2002) Lupus systémique chez les non-Caucasiens. Revue du Rhumatisme 69:8, pages 801-808.
Crossref
Crossref
D E GladstoneA A Prestrud, A Pradhan, M J Styler, D L Topolsky, P A Crilley, S Hoch, A Huppert & I Brodsky. (2016) High-dose cyclophosphamide for severe systemic lupus erythematosus. Lupus 11:7, pages 405-410.
Crossref
Crossref
Jacqueline Trager & Michael M. Ward. (2001) Mortality and causes of death in systemic lupus erythematosus. Current Opinion in Rheumatology 13:5, pages 345-351.
Crossref
Crossref
ROSALIND RAMSEY-GOLDMAN & SUSAN MANZI. 2000. Women and Health. Women and Health
704
723
.
Yoshiaki Tokano, Hirofumi Amano, Syhei Takai, Kenjiro Yamanaka, Masahiro Sugawara, Yoshinari Takasaki & Hiroshi Hashimoto. (1999) Long-term prognosis in lupus nephritis: relation to the renal biopsy data, therapy, and grade of remission. Japanese Journal of Rheumatology 9:2, pages 135-145.
Crossref
Crossref
Ricard Cervera, Munther A. Khamashta, Josep Font, Gian Domenico Sebastiani, Antonio Gil, Paz Lavilla, A. Olcay Aydintug, Anna Jedryka-Góral, Enrique de Ramón, Antonio Fernández-Nebro, Mauro Galeazzi, Hans-Jacob Haga, Alessandro Mathieu, Frédéric Houssiau, Guillermo Ruiz-Irastorza, Miguel Ingelmo & Graham R.V. Hughes. (1999) Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients. Medicine 78:3, pages 167-175.
Crossref
Crossref
ET Koh, A. Seow, KH Leong & HH Chng. (2016) SLE mortality in an oriental population. Lupus 6:1, pages 27-31.
Crossref
Crossref
Michael M. Ward, Elise Pyun & Stephanie Studenski. (2005) Causes of death in systemic lupus erythematosus, long‐term followup of an inception cohort. Arthritis & Rheumatism 38:10, pages 1492-1499.
Crossref
Crossref
H. Bootsma, P. Spronk, G. de Boer, P. Limburg, C. Kallenberg, R. Derksen, J. Wolters-Dicke, F. Gmelig-Meyling, L. Kater & J. Hermans. (1995) Prevention of relapses in systemic lupus erythematosus. The Lancet 345:8965, pages 1595-1599.
Crossref
Crossref
Michael M. Ward, Elise Pyun & Stephanie Studenski. (1995) Long-term survival in systemic lupus erythematosus patient characteristics associated with poorer outcomes. Arthritis & Rheumatism 38:2, pages 274-283.
Crossref
Crossref
S.S. Lee, C.S. Li & P.C.K. Li. (2016) Clinical Profile of Chinese Patients with Systemic Lupus Erythematosus. Lupus 2:2, pages 105-109.
Crossref
Crossref